AbTherx, Inc.: AbTherx Announces License Agreement with Gilead

License from Gilead grants AbTherx worldwide rights to a novel human therapeutic antibody discovery platformMOUNTAIN VIEW and SAN DIEGO, CA / ACCESSWIRE / June 7, 2023 / AbTherx, Inc., a privately held

Related Keywords

Zeiten , Mecklenburg Vorpommern , Germany , Justin Mika , Stefan Klotter , Abtherx Inc , Nasdaq , Abtherx Inc View , Gilead Sciences Inc , Gilead Sciences , Chief Executive Officer , Atlas Mouse , Inc View , Stabile Ertr , Chart Profi Stefan Klotter , Blue Chips , Abtherx , Nnounces , License , Agreement , Wilead ,